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ABSTRACT
XRCC1 protein is essential for mammalian viability
and is required for the efficient repair of single
strand breaks (SSBs) and damaged bases in
DNA. XRCC1-deficient cells are genetically unstable
and sensitive to DNA damaging agents. XRCC1 has
no known enzymatic activity and is thought to act
as a scaffold protein for both SSB and base exci-
sion repair activities. To further define the defects
leading to genetic instability in XRCC1-deficient
cells, we overexpressed the AP endonuclease
APE1, shown previously to interact with and be
stimulated by XRCC1. Here, we report that the over-
expression of APE1 can compensate for the impaired
capability of XRCC1-deficient cells to repair SSBs
induced by oxidative DNA damage, both in vivo
and in whole-cell extracts. We show that, for this
kind of damage, the repair of blocked DNA ends is
rate limiting and can be performed by APE1.
Conversely, APE1 overproduction resulted in a
3-fold increase in the sensitivity of XRCC1-deficient
cells to an alkylating agent, most probably due to
the accumulation of SSBs. Finally, the overproduc-
tion of APE1 results in increases of 40% in the
frequency of micronuclei and 33% in sister chroma-
tid exchanges of XRCC1
  cells. These data suggest
that the spontaneous generation of AP sites could
be at the origin of the SSBs responsible for the
spontaneous genetic instability characteristic of
XRCC1-deficient cells.
INTRODUCTION
Thousands of single strand breaks (SSBs) in DNA are formed
each day in a mammalian cell. They can arise directly from
reactions with endogenously generated reactive oxygen spe-
cies (ROS), or indirectly as intermediates in the repair of
damaged bases or abasic (AP) sites. It has been estimated
that the majority of the several thousand AP sites generated
per mammalian cell per day by both spontaneous depurination
and in the course of base excision repair (BER) reactions, are
readily cleaved and converted into SSBs (1). If not repaired,
SSBs cause genomic instability leading to increased mutation
rates and chromosomal rearrangements (2). In the case of their
induction by genotoxic challenges, they result in a reduction in
cell survival.
The Chinese hamster ovary (CHO) mutant EM9 cell line
was originally isolated by its hypersensitivity to alkylating
agents and is shown to be cross-sensitive to ionizing radiation
(3). EM9 cells display a high level of spontaneous or induced
sister chromatid exchanges (SCEs) (4) and a slower rate of
SSB repair (SSBR) when compared with the parental AA8 cell
line (3). All these phenotypes are due to the inactivation of the
XRCC1 gene (5). Although no enzymatic activity has been
ascribed toXRCC1, itsabsenceleadstoa substantialreduction
in the levels of its partner Ligase 3 (Lig3) (6). However, the
destabilization of Lig3 cannot account for all the phenotypes
that result from the inactivation of XRCC1 (7). The ﬁnding of
multiple interactions of XRCC1 with other DNA repair
enzymes, such as DNA polymerase b (Polb) (8,9), poly
(ADP-ribose) polymerases 1 and 2 (PARP 1 and 2) (8,10,11),
polynucleotide kinase (PNK) (12), AP endonuclease 1 (APE1,
also known as HAP1 or REF1) (13) and more recently, a
DNA glycosylase (14) and the proliferating cell nuclear
antigen (PCNA) (15), lead to the proposal that XRCC1 acts
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both BER and SSBR (13–16). The lack of coordination in the
repair process could result in the persistence and exposure to
the cellular milieu of potentially toxic DNA intermediates
such as SSBs.
Frequently SSBs, and in particular those generated by ROS,
carry chemical modiﬁcations at the 30 and/or 50-DNA termini
that impede further gap ﬁlling or religation. Among the most
common of such modiﬁcations encountered on the 30-terminus
are 30-phosphate (30-P), 30-phosphoglycolate (30-PG) or 30-
open aldehydes (30-dRP). The 30-dRP extremities are also
potentially formed as repair intermediates by the so-called
bi-functional DNA glycosylases during BER of oxidized
bases, although the in vivo relevance of the 30-dRP BER inter-
mediate is not known (17,18). Processing of the 30-blocked
ends is therefore required to complete repair. In mammalian
cells, several activities have been proposed to ‘clean’ 30-
termini (12,19). However, it is clear that the main activity
capable of removing 30-dRP is provided by APE1 (20). Bio-
chemical experiments using whole-cell extract (WCE)
showed that, in spite of its relative inefﬁciency in vitro, APE1
is also the rate-limiting activity for the removal of 30-PG
generated by the oxidation of AP sites or direct breaks
(21,22). As for the 30-P resulting from either direct breaks
by ROS or the activity of DNA glycosylases such as Neil1
or Neil2 (23), two enzymes are known to process them in vitro,
APE1 and PNK. Indeed, APE1, in addition to cleaving 50 of an
AP site, can also hydrolyze 30-P (20). Similarly, PNK displays
a3 0-phosphatase activity in addition to acting as a kinase
(12,24). Interestingly, both enzymes, APE1 and PNK, not
only interact with XRCC1 but also have their 30-phosphatase
activity stimulated by this protein in vitro (12,13). Stable
down-regulation of hPNK by small-interfering RNA sensitizes
cells to genotoxic agents (25). Similarly, cells with reduced
levels of APE, obtained by inactivation of one allele of the
mouse Apex gene (26), by antisense expression of the APE1
cDNA (27,28) or by siRNA expression (29) in human cell
lines, are hypersensitive toawiderangeofoxidativegenotoxic
agents. As these phenotypes, likely to result from a deﬁcient
repair of 30-blocked DNA ends generated by ROS, are similar
to those obtained in XRCC1-deﬁcient cells, some of the
xrcc1 /  phenotypes could result from the reduced capacity
of these cells to ‘clean’ 30-blocked ends (12). Here, by over-
expressing APE1 in EM9 cells and characterizing the resulting
cellular and biochemical phenotypes, we analyse some of the
potential mechanisms by which XRCC1 protects cells against
the consequences of DNA damage and explore the type of
spontaneous lesion that is most likely to contribute to the
genetic instability of XRCC1-deﬁcient cells.
MATERIALS AND METHODS
Cell lines and culture conditions
CHO cell lines AA8 and EM9 (5) were obtained from E. Sage
(Institut Curie, Paris). The XRCC1-complemented EM9-XH
cell line (30) was kindly provided by K. W. Caldecott
(University of Sussex). All the mammalian cell lines were
grown in DMEM containing sodium pyruvate and supplemented
with 10% foetal calf serum, 1% penicillin/streptomycin and
1% glutamine at 37 Ci na5 %C O 2 humidiﬁed atmosphere.
Overproduction of APE1 in CHO cell lines
In order to overproduce hAPE1 in EM9 or parental AA8 cells,
hAPE1 gene open reading frame was ampliﬁed by PCR using
the primers 50-CCGGAATTCATGCCGAAGCGTGGAAA-
AAGG and 50-GCTCTAGACAGTGCTAG GTA TAGGT
and inserted in the pcDNA3.1/myc-His A vector (Invitrogen)
between EcoRI and XbaI restriction sites. The resulting plas-
mid, pPR311, allows the expression of hAPE1 in frame with a
Myc epitope and a polyhistidine tag, under the control of the
cytomegalovirus promoter. Twenty four hours after transfec-
tion, cells were plated on 100 mm dishes with complete
medium containing 800 mg/ml of geneticin. Single clones
were isolated after 15 days and ampliﬁed.
For APE1 expression analysis, a total of 8 · 10
6 cells was
resuspended in 0.2 ml of lysis buffer [20 mM Tris–HCl, pH
8.0, 1 mM EDTA, 250 mM NaCl and 0.4 mM AEBSF (ICN
Biomedicals Inc.)] containing 0.8 mg/ml of antipain, 0.8 mg/ml
of aprotinin and 0.8 mg/ml of leupeptin, sonicated for 8 s (1 s
pulseevery10s)andcentrifugedat 4 Cfor1h at13000r.p.m.
The supernatant was recovered and its protein concentration
was determined using the Bio-Rad Protein Assay kit (Bio-
Rad). For the detection of hAPE1 by western blotting,
50 mg of WCE was separated by denaturing 12.5% PAGE
and transferred onto a nitrocellulose membrane (Hybond-C;
Amersham). A rabbit polyclonal anti-APE1 antibody (gift of
I. D. Hickson, University of Oxford) diluted to 1:1000 was
used to detect APE1.
APE1 cleavage assay
To test the enzymatic activity of hAPE1, a 34mer oligonucleo-
tide containing a tetrahydrofuranyl residue (F) (Eurogentec) at
position 16, was labelled at the 50 end using [g-
32P]ATP
(3000 Ci/mmol; Amersham) and T4 PNK (New England
Biolabs). The
32P-labelled strand was hybridized with the
complementary oligonucleotidecarryingacytosine(C)oppos-
ite F by incubation at 90 C for 10 min followed by slow
cooling down to room temperature. In a standard reaction
(16 ml ﬁnal volume), 50 fmol of the labelled duplex was
incubated in reaction buffer (25 mM Tris–HCl, pH 8.0,
1 mM MgCl2 and 0.4 mg/ml of BSA) with 100 ng of WCE
at 37 C for 45 min. The reaction was stopped by addition of
6 ml of formamide dye and heating at 95 C for 5 min. Products
wereresolvedbydenaturing20%PAGEinthepresenceof7M
urea.Gels were scannedand bandintensitiesquantiﬁed using a
Storm PhosphorImager (Molecular Dynamics).
Survival curves
Cultures at 80% conﬂuence were trypsinized and 100–800
cells were plated in 6-well plates. After incubation for 16 h,
cells were treated with methyl methanesulfonate (MMS)
(Sigma) for 1 h at 37 C in complete medium or with H2O2
(Sigma) for 20 min at 37 C in phosphate-buffered saline
(PBS). After treatment, the cells were washed with PBS.
Fresh culture medium was added and the cells were incubated
for 8 days to allow clones to grow. Clones were washed twice
with PBS, ﬁxed in a solution containing 20% acetic acid and
80% ethanol and stained with a 4% Giemsa solution (Reactifs
RAL) for 2 h. After washing with water, visible colonies were
counted. Each survival curve was carried out at least three
times for statistical evaluation.
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For the induction of SSBs, cells were either treated with tert-
butyl-hydroperoxide (75 mM) or H2O2 (75 mM) in DMEM
without supplements for 15 min at 37 C and 5% CO2.T o
induce AP sites and SSBs, the cells were incubated with
100 mM MMS in DMEM without supplements for 30 min
at 37 C and 5% CO2. The cells were washed twice and
then incubated at 37 C under culture conditions for the indi-
cated repair times before DNA damage analysis.
Quantification of DNA modifications by alkaline
elution
The alkaline elution assay originally described by Kohn et al.
(31) with the modiﬁcations described previously (32,33) was
used for the quantiﬁcation of SSB and T4 endonuclease
V-sensitive AP sites. Elution curves obtained with g-irradiated
cells were used for calibration, assuming that 6 Gy generate
1 SSB/106 bp (31). The numbers of DNA modiﬁcations
observed in untreated control cells (background levels)
were subtracted.
In vitro repair assays
To test the phosphatase activity of WCE, 100 fmol of a
32P-
labelled 34mer oligonucleotide containing an 8-oxoguanine
residue (8-oxoG) at position 16 (gift of J. Cadet, CEA) and
hybridized with its complementary oligonucleotide carrying a
cytosine (C) opposite 8-oxoG was incubated with 5 ng of
puriﬁed Fpg protein in a reaction mixture containing 20 mM
Tris–HCl, pH 7.6, 1 mM DTT, 1 mM EDTA and 50 mM NaCl
for 30 min. The resulting substrate, a 15mer 50-labelled with
32P carrying a one nucleotide gap with a 30-P, was incubated in
areactionmixturecontaining20mMTris–HCl,pH7.6,50mM
NaCl, 1 mM DTT and 10 mM MgCl2 in the presence of WCE.
The amounts of extract and the incubation times are indicated
in the legends to Figures 3 and 4. The reactions were stopped
by adding 6 ml of formamide dye and heating at 95 C for
5 min. The products were resolved by denaturing 20%
PAGE in the presence of 7 M urea. Gels were scanned and
band intensities quantiﬁed using a Storm PhosphorImager
(Molecular Dynamics).
To evaluate the overall repair, reactions were carried out as
described for the phosphatase assay but with the addition of
100 mM dGTP, 2 mM ATP, 25 mM phosphocreatine (di-Tris
salt; Sigma) and 2.5 mg of creatine phosphokinase (type I;
Sigma).
Determination of micronuclei
Trypsinized cells were resuspended in full culture medium and
 1 · 10
5 cells were ﬁxed on a microscope slide by cytospin
centrifugation and treatment with methanol at  20 C for 1 h.
After staining with bisbenzimide (Hoechst 33258) in Ca
2+-
and Mg
2+-free PBS, 2000 cells were analysed for the presence
of micronuclei with a ﬂuorescence microscope (Nikon, Japan).
Sister chromatid exchange assay
A total of 6 · 10
5 cells were plated in a 25 cm
2 ﬂask with
medium containing 6 mg/ml of BrdU. After two cell divisions
in the presence of BrdU (30 h), Colcemid (Sigma) was added
at a ﬁnal concentration of 0.1 mg/ml, for 2 h. Cells were then
washed with PBS, trypsinized, resuspended and centrifuged.
The resulting pellet was resuspended in 0.075 M KCl and
incubated for 15 min at 37 C. Before centrifugation, 100 ml
of the ﬁxative (methanol–acetic acid, 3:1) is added. The pellet
was resuspended in the ﬁxative and incubated overnight at
4 C. The cells were centrifuged, washed in a fresh ﬁxative,
and dropped onto wet slides. The slides were submerged in
10 mg/ml of Hoechst 33258 (Sigma) for 20 min, incubated for
2 h under UV light in a solution containing 0.3 M NaCl and
30 mM sodium citrate at pH 6.3 (SSC 2·, pH 6.3). The slides
wereplunged inSSC2·,pH6.3 at60 Cfor15 minandstained
with 1.5% Giemsa for 3–5 min.
RESULTS
Overproduction of APE1 in CHO cell lines
In order to overproduce the APE1 protein in XRCC1-deﬁcient
EM9 or parental AA8 cells, the open reading frame coding the
hAPE1 protein was cloned in frame with a myc tag and under
the control of a constitutive promoter into a mammalian
expression vector. After transfection, geneticin-resistant
clones were tested for the overexpression of APE1 by western
blotting. Independent clones were further selected by an
enhanced AP site cleavage activity of their WCEs. One
APE1 overproducing clone in each background (EM9-APE1
and AA8-APE1) was selected and characterized further. In
parallel, EM9 and AA8 cell lines were transfected with the
empty vector, to generate control cell lines EM9-V and
AA8-V, respectively. Figure 1 shows the characterization of
the WCE from the selected clones by western blotting, using
an antibody against APE1 and by cleavage activity assay on a
DNA substrate harbouring an AP site analogue. For the over-
producers, a new band is revealed by the APE1 antibody,
corresponding to the tagged protein expressed from the vector
(Figure 1A). The expression of the exogenous protein in the
APE1-myc
APE1
AA8 EM9
-V -APE1 -APE1 -V -XH -
AA8 EM9 _
-V -APE1 -APE1 -V -XH -
34-mer
15-mer
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B
Figure 1. OverexpressionofAPE1inCHOcelllines.(A)WCEsoftransfected
clones were analysed by western blotting using an anti-APE1 antibody. (B)
APE activity of the WCEs (100 ng of total protein from each cell line) was
measured by the cleavage of a 34mer duplex oligonucleotide carrying a
tetrahydrofuranyl residue at position 16 of the 50-
32P-labelled strand.
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the AP site-cleavage activity level (Figure 1B).
Acceleration of the repair of oxidative SSBs by APE1
overproduction in EM9 cells
EM9 cell lines were shown to be hypersensitive to a large
spectrum of genotoxic agents known to generate SSBs (7).
Among them, the agents causing an oxidative stress have
widely been used to study the XRCC1-deﬁcient cell lines
(4,34). The hypersensitivity of the XRCC1-deﬁcient cells to
oxidative agents is generally associated with their reduced
capacity to repair SSBs. To examine whether APE1 overpro-
duction could alleviate this phenotype, we treated different
EM9 cell lines with oxidants known to induce SSBs, and
measured the in vivo SSBR kinetics using the alkaline elution
assay. As expected, the XRCC1 deﬁciency in EM9 or EM9-V
cells resulted in a reduced repair rate of SSB induced by
tert-butyl-hydroperoxide when compared with EM9-XH
cells corrected by XRCC1 (Figure 2A). Expression of APE1
in EM9-APE1 cell line resulted in a signiﬁcant recovery of the
SSBR (Figure 2A). The repair kinetics for EM9-APE1 is
intermediate between that of the XRCC1-deﬁcient EM9
cells and that of the XRCC1-complemented EM9-XH cells.
Similar results were obtained when tert-butyl-hydroperoxide
was replaced by H2O2 as the damaging agent. When the cells
were allowed to repair for 10 min after exposure to 75 mM
H2O2, the levels of remaining SSBs in the APE1 overproducer
were again intermediate between those of EM9-V and EM-XH
(Figure 2B). Taken together, the above experiments show that
the overproduction of APE1 partially compensates for the
deﬁciency of XRCC1
  for repairing SSBs induced by ROS
and that, in XRCC1-deﬁcient cells, APE1 is able to accelerate
a rate-limiting step of the repair of ROS-induced SSB.
As outlined in Introduction, SSBs termini induced by oxi-
dative attack to DNA are frequently damaged and need to be
processedtorestore30-OHand50-Pmoietiestoallowgapﬁlling
andDNAligation (Figure3A).Since this canbea limiting step
in SSBR (16), we investigated the possibility that overexpres-
sing APE1 in the XRCC1-deﬁcient EM9 cells could accelerate
the repair by WCEs of a gap with 30-P, a common terminus
modiﬁcation found after DNA damage. We ﬁrst compared the
capacityofWCEstomediatetheremovalofa30-PfromaDNA
substrate harbouring a gap with a 30-P. EM9-V cell extracts
were less able to remove the 30-P, than the extracts from EM9-
XH, reﬂecting a deﬁciency of the XRCC1
  cells in their 30-
phosphatase activity (Figure 3B, cf. lanes 2–5 and 6–9). When
extracts from the APE1 overproducing cell line were tested,
they displayed an even greater 30-phosphatase activity than the
onefromtheXRCC1-complementedcellline.Kineticsexperi-
ments conﬁrmed that EM9-APE1 cell extracts repair (‘clean’)
30-P termini faster than the XRCC1 complemented EM9-XH
extracts (Figure 3C). These data demonstrate that an overex-
pression of APE1 in EM9 cells can compensate for their deﬁ-
ciency in the repair of a 30-blocked end.
As the ligation step of SSBR (Figure 3A) in XRCC1-
deﬁcient cells is known to be impaired, we wished to examine
whether the removal of the 30-P was a limiting step in the
overall repair by WCE of our gap substrate by adding to the
reaction mixture, dGTP and ATP, and therefore allowing
the nucleotide incorporation and ligation steps to proceed
(Figure 3A). As expected, the overall repair of a 30-P gap by
WCE was slower in extracts from EM9-V than in those from
EM9-XH (Figure 4A and C). Surprisingly, the expression of
APE1 in EM9 cells was able to restore the overall repair to
levels even higher than those of EM9-XH (Figure 4A, 34mer
bandandC).TheaccumulationoftheintermediateDNAresult-
ingfromtheincorporationofonenucleotide(Figure4AandB)
indicates that APE1 overexpression cannot circumvent the
ligase deﬁciency. However, the increased availability of the
polymerase substrate (30-OH gap), shown in Figure 3B and
C, allowed the EM9-APE1 WCE to reach an overall repair
rate higher than that of EM9-XH extracts (Figure 4A). This
is reﬂected in Figure 4C, where the ﬁnal DNA product (34mer)
arising from the gap ﬁlling and ligation reactions in the various
cellextractsisplottedasafunctionoftheincubationtime.From
the experiments with WCE, we conclude that in xrcc1 / 
cells,atleastinthecaseofa30-P,theremovalofthe30-blocking
lesion is a rate-limiting step in SSBR.
While the exposure to increasing concentrations of H2O2
or tert-butyl-hydroperoxide conﬁrmed the hypersensitivity to
oxidizing agents of EM9-V cells when compared to EM9-XH
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Figure 2. In vivo repair of ROS-induced SSBs induced by oxidative stress.
(A) Residual SSBs were quantified by the alkaline elution method at different
times after treatment of the cells with 75 mM tert-butyl-hydroperoxide. The
valuesgivenarethemeanofthreeindependentexperiments–SD.(B)Residual
SSBs were quantified 10 min after the end of treatment with 75 mMH 2O2 for
15 min at 37 C. Values are the mean of at least three independent
experiments – SD. *P < 0.02.
Nucleic Acids Research, 2005, Vol. 33, No. 1 301expressing XRCC1, increasing cellular levels of APE1 does
not improve the resistance of EM9 cells to H2O2 or tert-butyl-
hydroperoxide (data not shown).
Accumulation of SSBs in APE1-overexpressing cells
treated with an alkylating agent
Alkylating agents such as MMS generate high levels of AP
sites, both by spontaneous depurination and in the course of
BER ofalkylated DNA bases. The repair defect inEM9 cells is
known to be associated with a pronounced hypersensitivity to
alkylating agents and increased accumulation of SSB after
treatment (3). We therefore wished to examine whether the
defective processing of AP sites generated by MMS in EM9
cells could be modiﬁed by the overexpression of APE1. We
compared the accumulation of AP sites and SSBs 0 and 15 min
after exposure of the various cell lines to 100 mM MMS for
30 min at 37 C (Figure 5A). When compared with the XRCC1
complemented cells (EM9-XH), EM9-V cells showed higher
levels of SSBs at both times analysed. The AP site levels in
EM9-V cells were also elevated at the end of the treatment but
after 15 min of recovery they were comparable to the levels in
EM9-XHcells.TheseresultsshowthattheAPsitesinducedby
the treatment are processed more slowly in the XRCC1-
deﬁcient cells and that SSBs accumulate during the recovery
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Figure 3. Phosphate removal from a 30-P gap. (A) Schematic representation of
the enzymatic reactions involved in the repair of a 30-P harbouring gap. Initial
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5,9and13)ofWCEproteinsfromtheindicatedcelllines.Productswereseparated
bydenaturingPAGE.(C)30-Pharbouringgapsubstrate(i)wasincubatedwith1mg
of WCE of the indicated cell lines at 37 C and aliquots of each reaction were
removed at the times indicated. The resulting products were separated by
denaturing PAGE and the conversion of the 30-P into 30-OH was quantified.
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Figure 4. Overall repair of a 30-P gap. The initial gap substrate shown in
Figure 3A (i) was incubated at 37 C with 1 mg of protein from WCE from
the indicated cell lines in the presence of ATP and dGTP. Aliquots of each
reactionwereremovedat5(lanes2,6and10),10(lanes3,7and11),20(lanes4,
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resultedindecreasedlevelsofAPsiteswhencomparedtothose
in EM9-V cells. However, the SSBs accumulated in the APE1-
overproducing cells at higher levels than in the EM9-V cells.
These results suggest that by overproducing APE1 in an
XRCC1-deﬁcient background, the cells readily cleave the
induced AP sites, generating high levels of SSBs that cannot
be processed efﬁciently owing to a downstream rate-limiting
step. Further support for the negative consequences of an im-
balance in the proteins responsible for the repair of AP sites
emerged from the observation that EM9-APE1 cells exhibited
an increased sensitivity to MMS, compared with the EM9-V
cells (Figure 5B). In contrast, as it was previously shown (35–
38),theoverproductionofAPE1didnotaffectthesensitivityof
the AA8 (XRCC1-proﬁcient) cells to MMS even at very high
concentrations of the genotoxic agent (Figure 5C).
The results from the repair of MMS-induced damage, along
with the MMS sensitivity curves show that in XRCC1-
defective cells, in contrast to the situation observed for the
repair of ROS-induced SSBs, the rate-limiting step in the
repair of normal abasic sites is downstream of the generation
of the 30-OH harbouring SSBs by the APE1.
Overexpression of APE1 in EM9 cells increases
spontaneous genomic instability
One of the landmark phenotypes of XRCC1-defective cells is
theirhighlevelofSCEwhengrowninthepresenceofBrdUfor
onecellcycle(3,39).EM9cellsalsodisplayanelevatednumber
of spontaneous chromosomal breaks when compared with the
parental XRCC1-proﬁcient cells. Both phenotypes have been
attributed to a deﬁcient repair of DNA lesions resulting in
increased levels of SSBs (2,7). The results presented above
show that the overproduction of APE1 in EM9 cells had oppo-
siteeffectsontherepairofDNAdependingonthetypeoflesion
present on DNA. Therefore, an analysis of the effect of over-
producing APE1 in EM9 cells on the genetic stability in
otherwise untreated cells should indicate which type of endo-
genous lesion contributes most to the genetic instability of
untreated EM9 cells. Towards this purpose, we compared the
number of micronuclei in the different EM9 cell lines used
above. Table 1 shows that APE1 overproduction resulted in
a 40% increase in micronuclei levels, a signiﬁcant difference
withthealreadyelevatedonesfoundinEM9cells.Spontaneous
SCE numbers (Table 2) also show a signiﬁcant increase (33%)
intheAPE1overproducerswithrespecttothenumberfoundfor
EM9-V, which is almost 7-fold higher than that of EM9-XH
cells. These data suggest that the SSBs resulting from cleavage
ofendogenouslygeneratedAPsitescouldbeanimportantcause
of the genetic instability displayed by XRCC1-defective cells,
while the SSBs generated by endogenously produced ROS
appear to be less relevant.
DISCUSSION
XRCC1 and repair of AP sites
The 50-dRP removal by Polb is a rate-limiting step for single-
nucleotide BER (40,41) in mammalian cells. Because XRCC1
has been shown to interact both physically and functionally
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Figure 5. Responses to MMS. (A) Levels of SSBs and AP sites induced by
treating various CHO cell lines with 100 mM MMS for 30 min at 37 Ca s
determinedbyalkalineelutionattheendofthetreatment(0min)orafter15min
of recovery. (B and C) Effect of APE1 overproduction on survival to MMS
treatment. Cells were treated with MMS for 1 h at 37 C at the indicated doses.
Surviving clones (>50 cells) were scored after 8 days. Values represent the
mean of at least three independent experiments – SD.
Table1.MicronucleifrequenciesareenhancedinEM9cellsbyoverproduction
of APE1
Cell lines Micronuclei/2000 nuclei
Mean SD
EM9-XH 45 4
EM9-V 65 9
EM9-APE1 91
* 14
SD, standard deviation.
*P<0.005(Student’st-test)forthedifferencebetweenEM9-VandEM9-APE1.
Table 2. APE1 overexpression increases the level of sister chromatid
exchanges
Cell lines SCEs/cell
Mean SEM
EM9-XH 6.9 0.4
EM9-V 45.5 1.4
EM9-APE1 60.6
* 1.8
SEM, standard error of the mean.
*P<0.0001(Mann–Whitneytest)forthedifferencebetweenEM9-VandEM9-
APE1.
Nucleic Acids Research, 2005, Vol. 33, No. 1 303withAPE1, PolbandLig3(42),MMShypersensitivityofEM9
cells could potentially be due to a deﬁciency in any of the
enzymatic steps involved in the repair of the induced AP sites.
Previous studies had shown that, in XRCC1-proﬁcient cells,
overproduction of APE1 did not affect the sensitivity of the
cells to MMS (35–38). The surprising 3-fold increase in sens-
itivity of the EM9 cells to MMS by the overexpression of
APE1, along with the increased accumulation of SSBs after
treatment suggests that the more efﬁcient processing of AP
sites results in cleaved DNA intermediates that cannot be
processed efﬁciently by the later steps of BER (or SSBR)
due to the lack of XRCC1. This suggests that either the
Polb reactions or, more likely, the ligation step are limiting
for the repair of normal abasic sites in XRCC1-deﬁcient cells.
Thelackofcoordinationbetweenthedifferentenzymaticsteps
resulting from the absence of XRCC1 could also contribute to
the hypersensitivity of EM9 cells to alkylating agents. By
holding intermediate DNA substrates and handing them
over to the next enzyme in the pathway, XRCC1 prevents
potentially toxic BER or SSBR intermediates (single-stranded
DNA, unligatable nicks, etc.) from being exposed to the cel-
lular milieu (7,43). Therefore, accelerating the cleavage of AP
sites without a concomitant increase in the downstream repair
activities can lead to an excess of SSBs that cannot be pro-
cessed correctly before triggering other reactions comprom-
ising cell viability.
Role of XRCC1 in oxidative SSBR
A very different scenario is observed for oxidative DNA dam-
age processing in EM9 cells. APE1 overexpression could, in
part, compensate for the defective repair kinetics of SSBs
induced by oxidative agents such as H2O2 or tert-butyl-hydro-
peroxide(Figure2).TheexperimentspresentedinFigures3and
4 indicate that the APE1 overexpression accelerates SSBR in
EM9cells by improvingthe processing(’cleaning’)ofblocked
30-termini.Therepairdeﬁciency ofEM9cellsatthisstepcould
be,inpart,owingtoalackofactivationofeitherPNKorAPE1.
AlthoughithasbeenproposedthatPNKistheenzymerespons-
iblefortheremovalof30-Pincellextracts(24),ourexperiments
show that APE1 can also perform the reaction to yield a 30-OH
and allow repair to be completed. Interestingly, APE1 has also
been shown to provide the main activity for the removal of
another 30-blocking lesion, 3-PG (22). Taken together, these
results suggest the involvement of APE1 in SSBR.
The experiments presented here also shed some light on the
rate-limiting step in the repair of oxidative lesions. In the case
of oxidative DNA damage leading to 30-blocked ends, the
removal of the blocking lesion is the limiting activity in
XRCC1-deﬁcient cells. Overexpressing APE1 could therefore
relieve the slow repair phenotype by accelerating the removal
of 30-blocks. Consistently, HeLa cells display an increase in
APE1 mRNA and protein when exposed to ROS (44), suggest-
ing a mechanism to accelerate a rate-limiting step. The partial
nature of the correction of SSBs displayed in Figure 2 is not
surprising since 30-blocked SSBs are only a subset of lethal
lesions induced by those treatments. Genotoxic lesions other
than 30-blocked ends can also explain the lack of signiﬁcant
complementation of EM9 sensitivity to H2O2. Moreover, this
lack of protection at the survival level does not exclude the
possibility that the overproduction of APE1, by accelerating
SSBR and hence shortening the persistence of SSBs, could
protect EM9 cells from other deleterious consequences of
oxidative DNA damage, such as mutations or chromosomal
rearrangements.
APE1 levels, XRCC1 and genetic instability
InBER,thebalancedlevelsofthedifferentproteinscarryingout
the enzymatic steps are a requisite to modulate their respective
activities and to avoid the accumulation of potentially toxic
repair intermediates (45). As shown here, overexpression of
a repair activity can have opposite effects depending on the
kind of lesion to be taken care of. In the case of APE1 over-
production in EM9 cells, this expression can accelerate a po-
tentially rate-limiting step in the repair of ROS-induced DNA
damage.Itwasindeedshownthatheterozygosityforthemouse
APEresultsinphenotypesassociatedwithoxidativestress(26).
Conversely, the consequences of MMS-induced damage seem
to be exacerbated by the overexpression of APE1 in EM9 cells
leading to enhanced sensitivity. This is unlike in XRCC1-
proﬁcient cells, where increasing the APE1 levels does not
affect the sensitivity phenotypes (35–38). Interestingly, the
increased expression of APE1 has been reported in several
kinds of tumours (29,46–48), suggesting that the imbalance
created by this overexpression of a BER enzyme can lead to
geneticinstability,asitisthecaseforPolboverexpression(49).
The experiments presented above could also provide some
hints on the kind of spontaneous lesions at the origin of the
genetic instability in XRCC1-deﬁcient cells. Indeed, the over-
production of APE1 in an xrcc1 /  background leads to an
increased number of spontaneous SCE as well as micronuclei.
Since the overexpression of APE1 in EM9 cells accelerates the
repair of SSBs generated by ROS (Figure 2) while having
negative consequences on the processing of normal AP
sites, it is tempting to speculate that SSBs arising from the
processing of endogenously generated AP sites are more rel-
evant for leading to the chromosomal instability characteristic
of XRCC1-deﬁcient cells than oxidized SSBs resulting from
endogenous ROS generation.
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